Key result
Prototype apical access and closure devices aim to facilitate truly percutaneous transcatheter transapical procedures.
The development of apical access and closure devices represents an important step toward enabling truly percutaneous transcatheter transapical heart valve procedures.
Answers are grounded in this paper and cite their sources.
Device prototypes do not yet support clinical adoption; leaves open feasibility of percutaneous transapical access pending trials.
The majority of transcatheter aortic valve implantations, structural heart procedures and the newly developed transcatheter mitral valve repair and replacement are traditionally performed either through a transfemoral or a transapical access site, depending on the presence of severe peripheral vascular disease or anatomic limitations. The transapical approach, which carries specific advantages related to its antegrade nature and the short distance between the introduction site and the cardiac target, is traditionally performed through a left anterolateral mini-thoracotomy and requires rib retractors, soft tissue retractors and reinforced apical sutures to secure, at first, the left ventricular apex for the introduction of the stent-valve delivery systems and then to seal the access site at the end of the procedure. However, despite the advent of low-profile apical sheaths and newly designed delivery systems, the apical approach represents a challenge for the surgeon, as it has the risk of apical tear, life-threatening apical bleeding, myocardial damage, coronary damage and infections. Last but not least, the use of large-calibre stent-valve delivery systems and devices through standard mini-thoracotomies compromises any attempt to perform transapical transcatheter structural heart procedures entirely percutaneously, as happens with the transfemoral access site, or via a thoracoscopic or a miniaturised video-assisted percutaneous technique. During the past few years, prototypes of apical access and closure devices for transapical heart valve procedures have been developed and tested to make this standardised successful procedure easier. Some of them represent an important step towards the development of truly percutaneous transcatheter transapical heart valve procedures in the clinical setting.
No takes yet. Share an insight, caveat, or question.
Enrico Ferrari (2016) conducted a review in transcatheter heart valve procedures. Apical access and closure devices was evaluated. Prototypes of apical access and closure devices for transapical heart valve procedures have been developed to facilitate truly percutaneous transcatheter transapical procedures.
Synapse has enriched 10 related papers. Consider them for comparative context: